Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease | Journal of Pharmacology and Experimental Therapeutics
Energies | Free Full-Text | Wave Energy in the Mediterranean Sea: Resource Assessment, Deployed WECs and Prospects
Pharmaceuticals | Free Full-Text | Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
Classification methods in the diagnosis of breast cancer